Glaukos Corp Sustainability Reports
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing micro-invasive therapies for glaucoma, corneal disorders, and retinal diseases.
Sector: Manufacturing
Country: United States
Exchange: New York Stock Exchange
LEI: 5299004JA1LHE21M6T14
FIGI: BBG001T91NX8
11 reports from 2019 to 2025
